Logo image of QTRX

QUANTERIX CORP (QTRX) Stock Price, Quote, News and Overview

NASDAQ:QTRX - Nasdaq - US74766Q1013 - Common Stock - Currency: USD

6.135  +0.01 (+0.25%)

QTRX Quote, Performance and Key Statistics

QUANTERIX CORP

NASDAQ:QTRX (6/23/2025, 11:31:53 AM)

6.135

+0.01 (+0.25%)

Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryLife Sciences Tools & Services
Statistics
52 Week High16.74
52 Week Low4.05
Market Cap238.22M
Shares38.83M
Float36.35M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)08-06 2025-08-06/amc
IPO12-07 2017-12-07


QTRX short term performance overview.The bars show the price performance of QTRX in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 -20 -40

QTRX long term performance overview.The bars show the price performance of QTRX in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of QTRX is 6.135 USD. In the past month the price increased by 27.23%. In the past year, price decreased by -52.3%.

QUANTERIX CORP / QTRX Daily stock chart

QTRX Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
TMO THERMO FISHER SCIENTIFIC INC 18.1 149.60B
DHR DANAHER CORP 26.17 139.53B
A AGILENT TECHNOLOGIES INC 21.34 32.85B
IQV IQVIA HOLDINGS INC 13.74 26.86B
MTD METTLER-TOLEDO INTERNATIONAL 28.43 23.90B
WAT WATERS CORP 28.66 20.31B
WST WEST PHARMACEUTICAL SERVICES 32.57 15.54B
ILMN ILLUMINA INC 27.18 14.33B
ICLR ICON PLC 10.78 11.75B
TEM TEMPUS AI INC N/A 11.72B
RVTY REVVITY INC 19.13 11.12B
QGEN QIAGEN N.V. 20.2 10.06B

About QTRX

Company Profile

QTRX logo image Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The company is headquartered in Billerica, Massachusetts and currently employs 471 full-time employees. The company went IPO on 2017-12-07. The firm develops and commercializes ultra-sensitive digital immunoassay platforms that advance life sciences research and diagnostics. Its platforms are based on its proprietary digital Simoa detection technology. Its Simoa bead-based and planar array platforms enable customers to detect protein biomarkers in low concentrations in blood, serum, and other fluids. The firm's Simoa technology is based on traditional enzyme-linked immunosorbent assay (ELISA) technology. Its products include HD-X, SR-X, SP-X, Simoa assays and consumables, Nova Beads, and neurofilament light chain (NfL) antibodies and NfL ELISA kits. The company also offers contract research services for customers and laboratory developed test services through its Accelerator Laboratory, which provides customers with access to Simoa technology and supports multiple projects and services, including sample testing, homebrew assay development and custom assay development.

Company Info

QUANTERIX CORP

900 Middlesex Turnpike

Billerica MASSACHUSETTS 01821 US

CEO: E. Kevin Hrusovsky

Employees: 471

QTRX Company Website

QTRX Investor Relations

Phone: 16173019400

QUANTERIX CORP / QTRX FAQ

What is the stock price of QUANTERIX CORP today?

The current stock price of QTRX is 6.135 USD. The price increased by 0.25% in the last trading session.


What is the ticker symbol for QUANTERIX CORP stock?

The exchange symbol of QUANTERIX CORP is QTRX and it is listed on the Nasdaq exchange.


On which exchange is QTRX stock listed?

QTRX stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for QUANTERIX CORP stock?

11 analysts have analysed QTRX and the average price target is 11.63 USD. This implies a price increase of 89.54% is expected in the next year compared to the current price of 6.135. Check the QUANTERIX CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is QUANTERIX CORP worth?

QUANTERIX CORP (QTRX) has a market capitalization of 238.22M USD. This makes QTRX a Micro Cap stock.


How many employees does QUANTERIX CORP have?

QUANTERIX CORP (QTRX) currently has 471 employees.


What are the support and resistance levels for QUANTERIX CORP (QTRX) stock?

QUANTERIX CORP (QTRX) has a support level at 6.11 and a resistance level at 6.13. Check the full technical report for a detailed analysis of QTRX support and resistance levels.


Is QUANTERIX CORP (QTRX) expected to grow?

The Revenue of QUANTERIX CORP (QTRX) is expected to decline by -8.84% in the next year. Check the estimates tab for more information on the QTRX EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy QUANTERIX CORP (QTRX) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does QUANTERIX CORP (QTRX) stock pay dividends?

QTRX does not pay a dividend.


When does QUANTERIX CORP (QTRX) report earnings?

QUANTERIX CORP (QTRX) will report earnings on 2025-08-06, after the market close.


What is the Price/Earnings (PE) ratio of QUANTERIX CORP (QTRX)?

QUANTERIX CORP (QTRX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.19).


What is the Short Interest ratio of QUANTERIX CORP (QTRX) stock?

The outstanding short interest for QUANTERIX CORP (QTRX) is 7.89% of its float. Check the ownership tab for more information on the QTRX short interest.


QTRX Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to QTRX. When comparing the yearly performance of all stocks, QTRX is a bad performer in the overall market: 91.89% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

QTRX Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to QTRX. QTRX has a great financial health rating, but its profitability evaluates not so good.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

QTRX Financial Highlights

Over the last trailing twelve months QTRX reported a non-GAAP Earnings per Share(EPS) of -1.19. The EPS decreased by -23.96% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -14.89%
ROE -18.66%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-61.54%
Sales Q2Q%-5.4%
EPS 1Y (TTM)-23.96%
Revenue 1Y (TTM)33.16%

QTRX Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 78% to QTRX. The Buy consensus is the average rating of analysts ratings from 11 analysts.

For the next year, analysts expect an EPS growth of -57.46% and a revenue growth -8.84% for QTRX


Ownership
Inst Owners89.8%
Ins Owners5.62%
Short Float %7.89%
Short Ratio3.62
Analysts
Analysts78.18
Price Target11.63 (89.57%)
EPS Next Y-57.46%
Revenue Next Year-8.84%